Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer

Bradley Downs, Yeong C. Kim, Fengxia Xiao, Carrie Snyder, Peixian Chen, Elizabeth A. Fleissner, Dina Becirovic, Hongxiu Wen, Simon Sherman, Kenneth H. Cowan, Henry T. Lynch, San Ming Wang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Partner and localizer of BRCA2 (PALB2), plays an important functional role in DNA damage repair. Recent studies indicate that germline mutations in PALB2 predispose individuals to a high risk of developing familial breast cancer. Therefore, comprehensive identification of PALB2 germline mutations is potentially important for understanding their roles in tumorigenesis and for testing their potential utility as clinical targets. Most of the previous studies of PALB2 have focused on familial breast cancer cases with normal/wild-type BRCA1 and BRCA2 (BRCAx). We hypothesize that PALB2 genetic mutations also exist in individuals with BRCA mutations (BRCA+). To test this hypothesis, PALB2 germline mutations were screened in 107 exome data sets collected from familial breast cancer families who were either BRCA1+ or BRCAx. Two novel heterozygous mutations predicted to alter the function of PALB2 were identified (c.2014G>C, p.E672Q and c.2993G>A, p.G998E). Notably, both of these mutations co-existed in BRCA1+ and BRCA1x families. These studies show that mutations in PALB2 can occur independent of the status of BRCA1 mutations, and they highlight the importance to include BRCA1+ families in PALB2 mutation screens.

Original languageEnglish
Pages (from-to)219-224
Number of pages6
JournalBreast Cancer Research and Treatment
Volume151
Issue number1
DOIs
StatePublished - May 1 2015

Fingerprint

Germ-Line Mutation
Mutation
Exome
Familial Breast Cancer
DNA Repair
DNA Damage
Carcinogenesis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

Downs, B., Kim, Y. C., Xiao, F., Snyder, C., Chen, P., Fleissner, E. A., ... Wang, S. M. (2015). Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer. Breast Cancer Research and Treatment, 151(1), 219-224. https://doi.org/10.1007/s10549-015-3358-7

Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer. / Downs, Bradley; Kim, Yeong C.; Xiao, Fengxia; Snyder, Carrie; Chen, Peixian; Fleissner, Elizabeth A.; Becirovic, Dina; Wen, Hongxiu; Sherman, Simon; Cowan, Kenneth H.; Lynch, Henry T.; Wang, San Ming.

In: Breast Cancer Research and Treatment, Vol. 151, No. 1, 01.05.2015, p. 219-224.

Research output: Contribution to journalArticle

Downs, B, Kim, YC, Xiao, F, Snyder, C, Chen, P, Fleissner, EA, Becirovic, D, Wen, H, Sherman, S, Cowan, KH, Lynch, HT & Wang, SM 2015, 'Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer', Breast Cancer Research and Treatment, vol. 151, no. 1, pp. 219-224. https://doi.org/10.1007/s10549-015-3358-7
Downs, Bradley ; Kim, Yeong C. ; Xiao, Fengxia ; Snyder, Carrie ; Chen, Peixian ; Fleissner, Elizabeth A. ; Becirovic, Dina ; Wen, Hongxiu ; Sherman, Simon ; Cowan, Kenneth H. ; Lynch, Henry T. ; Wang, San Ming. / Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer. In: Breast Cancer Research and Treatment. 2015 ; Vol. 151, No. 1. pp. 219-224.
@article{cbf1c74dff3d45288a7e9bb713cfb599,
title = "Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer",
abstract = "Partner and localizer of BRCA2 (PALB2), plays an important functional role in DNA damage repair. Recent studies indicate that germline mutations in PALB2 predispose individuals to a high risk of developing familial breast cancer. Therefore, comprehensive identification of PALB2 germline mutations is potentially important for understanding their roles in tumorigenesis and for testing their potential utility as clinical targets. Most of the previous studies of PALB2 have focused on familial breast cancer cases with normal/wild-type BRCA1 and BRCA2 (BRCAx). We hypothesize that PALB2 genetic mutations also exist in individuals with BRCA mutations (BRCA+). To test this hypothesis, PALB2 germline mutations were screened in 107 exome data sets collected from familial breast cancer families who were either BRCA1+ or BRCAx. Two novel heterozygous mutations predicted to alter the function of PALB2 were identified (c.2014G>C, p.E672Q and c.2993G>A, p.G998E). Notably, both of these mutations co-existed in BRCA1+ and BRCA1x families. These studies show that mutations in PALB2 can occur independent of the status of BRCA1 mutations, and they highlight the importance to include BRCA1+ families in PALB2 mutation screens.",
author = "Bradley Downs and Kim, {Yeong C.} and Fengxia Xiao and Carrie Snyder and Peixian Chen and Fleissner, {Elizabeth A.} and Dina Becirovic and Hongxiu Wen and Simon Sherman and Cowan, {Kenneth H.} and Lynch, {Henry T.} and Wang, {San Ming}",
year = "2015",
month = "5",
day = "1",
doi = "10.1007/s10549-015-3358-7",
language = "English",
volume = "151",
pages = "219--224",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer

AU - Downs, Bradley

AU - Kim, Yeong C.

AU - Xiao, Fengxia

AU - Snyder, Carrie

AU - Chen, Peixian

AU - Fleissner, Elizabeth A.

AU - Becirovic, Dina

AU - Wen, Hongxiu

AU - Sherman, Simon

AU - Cowan, Kenneth H.

AU - Lynch, Henry T.

AU - Wang, San Ming

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Partner and localizer of BRCA2 (PALB2), plays an important functional role in DNA damage repair. Recent studies indicate that germline mutations in PALB2 predispose individuals to a high risk of developing familial breast cancer. Therefore, comprehensive identification of PALB2 germline mutations is potentially important for understanding their roles in tumorigenesis and for testing their potential utility as clinical targets. Most of the previous studies of PALB2 have focused on familial breast cancer cases with normal/wild-type BRCA1 and BRCA2 (BRCAx). We hypothesize that PALB2 genetic mutations also exist in individuals with BRCA mutations (BRCA+). To test this hypothesis, PALB2 germline mutations were screened in 107 exome data sets collected from familial breast cancer families who were either BRCA1+ or BRCAx. Two novel heterozygous mutations predicted to alter the function of PALB2 were identified (c.2014G>C, p.E672Q and c.2993G>A, p.G998E). Notably, both of these mutations co-existed in BRCA1+ and BRCA1x families. These studies show that mutations in PALB2 can occur independent of the status of BRCA1 mutations, and they highlight the importance to include BRCA1+ families in PALB2 mutation screens.

AB - Partner and localizer of BRCA2 (PALB2), plays an important functional role in DNA damage repair. Recent studies indicate that germline mutations in PALB2 predispose individuals to a high risk of developing familial breast cancer. Therefore, comprehensive identification of PALB2 germline mutations is potentially important for understanding their roles in tumorigenesis and for testing their potential utility as clinical targets. Most of the previous studies of PALB2 have focused on familial breast cancer cases with normal/wild-type BRCA1 and BRCA2 (BRCAx). We hypothesize that PALB2 genetic mutations also exist in individuals with BRCA mutations (BRCA+). To test this hypothesis, PALB2 germline mutations were screened in 107 exome data sets collected from familial breast cancer families who were either BRCA1+ or BRCAx. Two novel heterozygous mutations predicted to alter the function of PALB2 were identified (c.2014G>C, p.E672Q and c.2993G>A, p.G998E). Notably, both of these mutations co-existed in BRCA1+ and BRCA1x families. These studies show that mutations in PALB2 can occur independent of the status of BRCA1 mutations, and they highlight the importance to include BRCA1+ families in PALB2 mutation screens.

UR - http://www.scopus.com/inward/record.url?scp=84937762907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937762907&partnerID=8YFLogxK

U2 - 10.1007/s10549-015-3358-7

DO - 10.1007/s10549-015-3358-7

M3 - Article

VL - 151

SP - 219

EP - 224

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -